The rise of Sildenafil initially drove a surge for pharma, however recent shifts present a uncertain scenario for those considering a stake. Lower-cost competitors are reducing revenue, and persistent litigation add https://amaantwsi547838.blogsmine.com/41501440/viagra-and-pharma-a-risky-investment